| View |
|
DRP-9229-02
|
Doxorubicin hydrochloride
|
Duxobin
|
2mg/mL (50mg/25mL)
|
Solution for Injection (I.V.)
|
Antineoplastic Agent (Anthracycline)
|
Venus Remedies Ltd
|
India
|
CLIDP Conversion
|
19 November 2022
|
14 October 2025
|
| View |
|
DRP-10088-03
|
Nicardipine Hydrochloride
|
Ardipin
|
1 mg/mL
|
Solution for IV Infusion
|
Calcium Channel Blocker
|
Furen Pharmaceutical Group Co., Ltd.
|
China
|
CLIDP Conversion
|
19 November 2022
|
15 May 2025
|
| View |
|
DRP-10322-05
|
Etoricoxib
|
Maricoxia-120
|
120 mg
|
Film-Coated Tablet
|
Non-steroidal Anti-inflammatory and Antirheumatic
|
Hiral Labs Limited
|
India
|
CLIDP Conversion
|
19 December 2022
|
10 September 2026
|
| View |
|
DRP-11150-01
|
Sitagliptin (as phosphate monohydrate) + Metformin Hydrochloride
|
Sitajack-M
|
50 mg/500 mg
|
Film Coated Tablet
|
Antidiabetic Agent(Dipeptidyl peptidase 4(DPP-4) Inhibitor/Biguanide)
|
Bafna Pharmaceutical Limited
|
India
|
CLIDP Conversion
|
19 November 2022
|
08 February 2027
|
| View |
|
DRP-11700-04
|
Omeprazole (as sodium)
|
Retazole
|
40 mg
|
Lyophilized Powder for Intravenous Injection/Infusion
|
Proton Pump Inhibitor
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
19 November 2022
|
25 April 2027
|
| View |
|
DRP-12551-01
|
Sodium Bicarbonate
|
None
|
84 mg/mL (8.4% w/v)
|
Solution for Injection (I.V.)
|
Electrolyte Replenisher/ Systemic Alkalinising Agent
|
Hebei Tiancheng Pharmaceutical Co., Ltd
|
China
|
CLIDP Conversion
|
19 November 2022
|
09 September 2027
|
| View |
|
DRP-12817-01
|
Sitagliptin (as phosphate monohydrate) + Metformin hydrochloride
|
Lupigliptin Plus
|
50mg/500mg
|
Film-Coated Tablet
|
Combination of Oral Blood Glucose Lowering Drugs
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
19 November 2022
|
29 November 2026
|
| View |
|
DRP-7404
|
Methylprednisolone (as sodium succinate)
|
Solu-Medrol
|
40 mg
|
Lyophilized Powder For Injection (IM/IV)
|
Corticosteroid
|
Pharmacia &Upjohn Company
|
U.S.A.
|
Automatic Renewal
|
02 December 2022
|
18 October 2027
|
| View |
|
DRP-1425-14
|
Amoxicillin (as Trihydrate)
|
Moxill 250
|
250 mg/5 mL
|
Powder for Suspension
|
-
|
J.M. Tolmann Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
01 December 2022
|
21 November 2026
|
| View |
|
DRP-10047-01
|
Prednisone
|
Kodasone
|
10 mg/5 mL
|
Suspension
|
Corticosteroid
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
29 June 2023
|
07 August 2028
|
| View |
|
DRP-11225-01
|
Oxaliplatin
|
Lipanox
|
2 mg/mL
|
Concentrate Solution for Injection (IV Infusion)
|
-
|
Bruck Pharma Private Limited
|
India
|
CLIDP Conversion
|
01 December 2022
|
15 February 2027
|
| View |
|
DRP-130101
|
Butamirate Citrate
|
Butacod Forte
|
7.5 mg/5 mL
|
Syrup
|
Antitussive
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
05 June 2023
|
30 September 2028
|
| View |
|
DRP-13095
|
Paracetamol
|
Westamol
|
250 mg / 5 mL
|
Syrup
|
Analgesic/Antipyretic
|
Lloyd Laboratories, Inc
|
Philippines
|
Renewal
|
16 March 2023
|
30 June 2028
|
| View |
DR-XY48486_PI_01.pdf
|
DR-XY48486
|
Silodosin
|
Ureleve
|
8mg
|
Capsule
|
-
|
Ajanta Pharma Limited
|
India
|
Monitored Release
|
23 November 2022
|
23 November 2027
|
| View |
|
DR-XY48482
|
Rivaroxaban
|
None
|
20 mg
|
Film-Coated Tablet
|
-
|
Beker Laboratories
|
Algeria
|
Initial
|
22 November 2022
|
22 November 2027
|
| View |
|
DRP-13061
|
Zinc Sulfate
|
Zincsulsaph
|
2.5 mg/mL (0.25% w/v)
|
Ophthalmic Solution (Eye Drops)
|
-
|
Kilitch Drugs (India) Ltd.
|
India
|
Initial (OTC)
|
24 November 2022
|
24 November 2027
|
| View |
|
DRHR-2168
|
Hydrogen Peroxide
|
Unbranded
|
3 g (3 % w/v) per 100 mL
|
Topical Solution
|
Antiseptic
|
International Pharmaceuticals, Inc.
|
Philippines
|
Renewal
|
27 July 2024
|
24 November 2029
|
| View |
|
DR-XY48490
|
Zinc Chelate
|
None
|
30 mg
|
Tablet
|
-
|
Nexgen Pharma, Inc.
|
United States of America
|
Initial
|
24 November 2022
|
24 November 2027
|
| View |
|
DRP-13040
|
Ascorbic Acid + Zinc+ Colecalciferol (Vitamin D3)
|
CGEN PLUS D200
|
500 mg (equivalent to 562.50 mg Sodium Ascorbate)/10
562.5 mg (equivalent to 70 mg Zinc Gluconate)/200 IU
|
Capsule
|
-
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
Initial (OTC)
|
21 November 2022
|
21 November 2027
|
| View |
|
DRP-13051
|
Sitagliptin (as phosphate) + Metformin Hydrochloride
|
KoztaTM Plus
|
50 mg/1g
|
Film-Coated Tablet
|
-
|
Intas Pharmaceuticals Limited.
|
India
|
Initial Reconstruction]
|
17 November 2023
|
23 November 2027
|